awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47580956-6A9A419B-C07B-428D-BB71-7253DA53C058
Q47580956-6A9A419B-C07B-428D-BB71-7253DA53C058
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47580956-6A9A419B-C07B-428D-BB71-7253DA53C058
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
P2860
Q47580956-6A9A419B-C07B-428D-BB71-7253DA53C058
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47580956-6A9A419B-C07B-428D-BB71-7253DA53C058
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6ad611ee10c8f8301f7ceb8b98a310bc5471632
P2860
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.